| European Case Law Identifier: | ECLI:EP:BA:2015:T112513.20150625 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 25 June 2015 | ||||||||
| Case number: | T 1125/13 | ||||||||
| Application number: | 05740675.3 | ||||||||
| IPC class: | A61K 39/095 A61K 47/48 G01N 33/50 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Combined meningococcal conjugates with common carrier protein | ||||||||
| Applicant name: | Novartis AG | ||||||||
| Opponent name: | GlaxoSmithKline Biologicals SA/ opposition withdrawn | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - inventive step (no) Auxiliary requests - not taken into account |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t131125eu1.html
Date retrieved: 17 May 2021